CGBIO Receives FDA 510(k) Clearance for Patient-Specific Titanium Implant ‘EASYMADE TI’
Patient-specific titanium implant designed for cranial and craniofacial reconstruction First Korean company to obtain FDA 510(k) clearance for a customized titanium implant in the U.S. market SEOUL, South Korea, April 24, 2026 /PRNewswire/ -- CGBIO (CEO: Hyunseung Yu) announced that its patient-specific titanium implant, EASYMADE TI, has received 510(k)...
Miracell Demonstrates Cognition Impairment and Brain Function Improvement in Severe Alzheimer’s Patients Using ‘SMART M-CELL’-Based CD34+ Cell-Rich Autologous Blood Concentrate Therapy
Study published in SCIE-indexed international journal Molecular Neurobiology Three intravenous infusions at four-week intervals showed benefits in cognition, brain metabolism, and structural preservation SEOUL, South Korea, April 24, 2026 /PRNewswire/ -- Miracell, a stem cell-focused biotechnology company, announced that clinical results have demonstrated significant cognitive improvement and preservation of brain function in patients with moderate to severe...
HanchorBio Selects Bloomberg to Strengthen its Strategic Intelligence Across Drug Development and Global Biopharma
Expanding HanchorBio's data-enabled approach from molecule design to portfolio and market insight TAIPEI and SHANGHAI and SAN FRANCISCO, April 24, 2026 /PRNewswire/ -- HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for immuno-oncology and immune-related diseases, today announced it has selected Bloomberg to support strategic decision-making across portfolio planning, pipeline development, competitive monitoring, business...
WuXi Biologics Chengdu Microbial Commercial Manufacturing Site Achieves Structural Completion and Key Equipment Arrival
CHENGDU, China, April 24, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced the structural completion and key equipment arrival at its microbial commercial manufacturing site in Chengdu, marking an important milestone as the company advances toward GMP release for production by the end of 2026. The microbial manufacturing site,...
CMUH and Partners Unveil Breakthrough Targeted Exosome Platform for Non-Invasive Spinal Cord Injury Repair
Developed by China Medical University Hospital, Ever Supreme International Biotechnology Co., Ltd. and SHINE OUT BIO TECHNOLOGY CO., LTD., the platform facilitates intravenous, lesion-targeted delivery of BDNF mRNA and improved motor coordination in preclinical models. TAICHUNG, April 24, 2026 /PRNewswire/ -- China Medical University Hospital (CMUH), in collaboration with Ever Supreme International Biotechnology Co., Ltd. and SHINE OUT BIO TECHNOLOGY...
Award-Winning XERF™ The Structural Skin Tightening Device, Now Available in Singapore
Cynosure Lutronic's non-invasive facial lifting and tightening device XERF™, recognised at the SBR Technology Excellence Awards 2026 is now offered at aesthetic clinics across Singapore. SINGAPORE, April 23, 2026 /PRNewswire/ -- Patients in Singapore now have access to XERF™, Cynosure Lutronic's Structural Skin Tightening device, at leading aesthetic clinics across the country, following the announcement of XERF™ winning at the...
Grand & Straits Optical Highlights Toa Payoh Outlet and Prepares to Introduce Meta Smart Eyewear in Singapore
SINGAPORE, April 24, 2026 /PRNewswire/ -- Grand & Straits Optical, a homegrown optical retailer serving Singapore's heartland communities for more than four decades, is spotlighting its Toa Payoh outlet as part of its ongoing commitment to providing customers with a wide selection of quality eyewear at accessible price points. Operated by Grand Optical & Contact Lens Pte Ltd and...
Daewoong Pharmaceutical Hosts ‘NABOTA Master Class’… Highlighting Safety Amid Growing Demand for High-Dose, Repetitive Treatments
74 healthcare professionals from 13 countries attended, recognizing the value of PrabotulinumtoxinA's "Safety" Comprehensive program including anatomy sessions, proprietary injection techniques, and 1:1 hands-on training Global participants praise the program as "a platform to share practical, clinically applicable toxin know-how" SEOUL, South Korea, April 24, 2026 /PRNewswire/...
MINISH Technology Accelerates Global Expansion with Next-Generation Biomimetic Solutions; Secures $110M Valuation
LOS ANGELES, April 23, 2026 /PRNewswire/ -- MINISH Technology, a dental health-tech company focused on preserving natural tooth structure, has secured a $22 million investment from VIG Partners. The deal gives VIG a 20% minority stake and values MINISH at approximately $110 million, roughly triple its valuation in 2023. minish veneers training course The funding comes as MINISH...
EVERISE NAMED LEADER IN EVEREST GROUP’S HEALTHCARE CUSTOMER EXPERIENCE MANAGEMENT PEAK MATRIX® 2026
PLANTATION, Fla., April 23, 2026 /PRNewswire/ -- Leading global healthcare customer experience provider Everise today announced that it has been named a Leader in Everest Group's Healthcare Customer Experience Management (CXM) Intelligent Operations PEAK Matrix® Assessment 2026 for the first time. This landmark recognition reinforces Everise's position at the forefront of healthcare customer experience, combining deep domain expertise with advanced...
